JAMA Psychiatry

Potential for Genomics to Help Guide Preventive Strategies in Psychiatry

Importance  Psychiatric disorders are a major source of disability and premature mortality worldwide. Advances in genomics have clarified parts of their genetic architecture, prompting questions about whether genomic information can inform preventive strategies for psychiatric disorders in clinical practice. This…

Updating Treatment Goals for Schizophrenia

This article discusses research providing renewed reasons to revisit the utility of glutamatergic drugs for treating schizophrenia.

Strategies for Establishing Clinical-Decision Thresholds in Psychiatry – A Review

Importance  Nearly all psychopathology is inherently continuous, but both clinical practice and research often require categorical decisions (eg, treat or wait, pay for treatment or decline, enroll in study or not); therefore, thresholds are applied to continuous phenomena to guide…

Blinding Integrity in Psychedelic Randomized Clinical Trials – A Systematic Review

Importance  Psychedelic drugs possess acute psychoactive effects that can compromise blinding integrity in randomized clinical trials (RCTs). Functional unblinding, when participants or raters correctly identify treatment allocation based on subjective effects, may bias outcomes through expectancy effects, challenging the validity…

A Ketogenic Diet for Treatment-Resistant Depression – A Randomized Clinical Trial

Importance  Preclinical evidence and case reports suggest potential therapeutic benefits of ketogenic diets (KDs) in the treatment of depression, but evidence from well-controlled randomized clinical trials (RCTs) is lacking. Objective  To assess the efficacy of a KD compared with a…

Patients Use AI—Clinicians Should Ask How

This article discusses the increasing prevalence of individuals seeking mental health help from artificial intelligence (AI) and recommends strategies to help patients navigate AI use.

Mental Disorders as Homeostatic Property Clusters – A Narrative Review

Importance  Psychiatric classification faces longstanding challenges, including heterogeneous diagnostic categories, high comorbidity rates, limited interrater reliability, and modest clinical utility. Successive revisions of systems such as the DSM since 1980 have done little to resolve these issues. How to move forward? Observations  This narrative…